InMed Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
IMLFF InMed Pharmaceuticals Inc
PNW Pinnacle West Capital Corp
AAPL Apple Inc
NAII Natural Alternatives International Inc
SJMiv.P Invesco BulletShares 2022 Hi Yld Corp Bd ETF
INTC Intel Corp
VAL Valaris PLC
GE General Electric Co
XOM Exxon Mobil Corp
MSFT Microsoft Corp

Health Care : Biotechnology | Small Cap Growth
Based in CanadaCompany profile

InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis based-therapies. The Company is working on two products, which include INM-750, for the treatment of Epidermolysis Bullosa (EB), and INM-085, for the treatment of Glaucoma. The INM-750 is a therapy developed for EB designed specifically to modulate disease activity and to alleviate symptoms. The INM-085 is designed as a dual-action cannabinoid ocular therapy. INM-085 is designed as a topical formulation to be administered directly to the eye. It is working on the development of several cannabinoid-based treatments for multiple diseases, including ocular, dermatology, cancer, inflammation, pain and arthritis disease areas. Its subsidiary is Biogen Sciences Inc. (BSI).

Closing Price
Day's Change
0.0234 (12.58%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Medicare Star Ratings show 3 out of 4 Aetna Medicare Advantage members enrolled in a 4.5 Star-rated plan or higher

8:30 am ET October 22, 2019 (PR Newswire) Print

Aetna, a CVS Health company (NYSE: CVS), announced its Medicare Advantage Prescription Drug (MAPD) plans have once again received higher-than-average ratings from the Centers for Medicare and Medicaid Services (CMS) in the annual Star Ratings, released on October 11. For 2020, Aetna's MAPD plans earned an overall weighted average rating of 4.3 out of 5.0 stars, with 76 percent (or 1.73 million) of its Medicare members enrolled in plans rated 4.5 stars or higher -- the highest percentage among publicly traded companies.*

Also noteworthy, approximately 99 percent of Aetna's Group Medicare Advantage members are enrolled in plans rated 4 stars or higher, with 96 percent in plans rated 4.5 stars or higher.

"This year's Star Ratings demonstrate that Aetna's approach to growing our Medicare business across the country, while maintaining best-in-class quality, is working," said Christopher Ciano, head of Aetna Medicare. "We saw a record-breaking volume of Aetna members in 4.5-star plans and we earned our first 5-star plan. By focusing on the total health of our members -- body, mind and spirit, and working closely with our physician partners and local communities to help our members age and thrive in place, we are transforming the way consumers experience Medicare in America."

Additionally, the SilverScript Prescription Drug Plan (PDP) -- the nation's largest PDP with 6 million members -- is the only PDP serving over 500,000 members in the industry to achieve 4 out of 5 stars. Through continued focus on medication adherence and strong operational processes, this contract delivers the high quality that our members deserve.

Aetna 5-Star Rated Contracts:

-- H3597 Aetna Health Inc. (ME HMO)

Aetna 4.5-Star Rated Contracts:

-- H1609 Aetna Health Inc. (FL/IA HMOs)

-- H3959 Aetna Health Inc. (PA HMO)

-- H5521 Aetna Life Insurance Company (AL, AZ, CA, CO, CT, DC, DE, FL, GA, IL, IN, KY, LA, MA, ME, MI, MS, NC, NJ, NV, NY, OH, PA, SC, TN, UT, VA, WA, WI, WY PPOs)

-- H5522 Health Assurance Pennsylvania, Inc. (PA PPO)

-- H7301 Coventry Health Care of Illinois (IL PPO)

Aetna 4-Star Rated Contracts:

-- H2663 Coventry Health Care of Missouri, Inc. (AR, IL, KS, MO, OK HMOs)

-- H3152 Aetna Health Inc. (NJ HMO)

-- H5793 Aetna Health Inc. (CT HMO)

-- R6694 Aetna Life Insurance Company (NJ, OH PPOs)

-- H7149 Aetna Health Inc. (NE HMO)

CMS' Medicare Star Ratings rank the performance and quality of Medicare Advantage and Medicare prescription drug plans to help beneficiaries and their families compare plans. Medicare Advantage plans are rated on how well they perform on five different categories:

-- Staying healthy

-- Managing chronic (long-term) conditions

-- Member experience with the health plan

-- Member complaints

-- Health plan customer service

Medicare Advantage Prescription Drug (MAPD) plans and stand-alone prescription drug plans (PDP) are also rated on how well they perform on three additional categories:

-- Drug plan customer service

-- Member experience with drug plan

-- Drug safety

Aetna Medicare Advantage and SilverScript prescription drug plans are available to Medicare beneficiaries for selection during the Annual Enrollment Period, which starts on October 15, 2019, and runs through December 7, 2019. Enrollment becomes effective on January 1, 2020.

The star ratings are posted at Visit to learn more about Aetna's 2020 Medicare plans or call toll-free at 1-855-335-1407 (TTY: 711). Hours are from 8 AM to 8 PM, local time, seven days a week.

NOTE: Information in this release is based on 2020 star ratings data published by CMS on October 11, 2019, and Medicare Advantage and Medicare prescription drug plan enrollment as of September 2019. Every year, Medicare evaluates plans based on a 5-star rating system.

*Includes publicly traded companies with over 250,000 Medicare Advantage enrollees.

About Aetna

Aetna, a CVS Health company, serves an estimated 38 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit and explore how Aetna is helping to build a healthier world. @AetnaNews

Aetna Medicare is a HMO, PPO plan with a Medicare contract. Our SNPs also have contracts with State Medicaid programs. Enrollment in our plans depends on contract renewal. See Evidence of Coverage for a complete description of plan benefits, exclusions, limitations and conditions of coverage. Plan features and availability may vary by service area.

SilverScript is a Prescription Drug Plan with a Medicare contract offered by SilverScript Insurance Company. Enrollment in SilverScript depends on contract renewal.

(C)2019 Aetna Inc. Y0001_4002_18555_M Accepted 10/2019

Media Contact: Ethan Slavin 860-273-6095

Investor Contact: Jennifer Lynch 860-273-1595

View original content to download multimedia:


Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.